biosector 2 limited
biosector 2 limited Company Information
Company Number
04460637
Next Accounts
Jan 2025
Industry
Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
Directors
Shareholders
syneos health communications uk limited
Group Structure
View All
Contact
Registered Address
10 bloomsbury way, london, WC1A 2SL
Website
biosector2.combiosector 2 limited Estimated Valuation
Pomanda estimates the enterprise value of BIOSECTOR 2 LIMITED at £3.4m based on a Turnover of £3.6m and 0.94x industry multiple (adjusted for size and gross margin).
biosector 2 limited Estimated Valuation
Pomanda estimates the enterprise value of BIOSECTOR 2 LIMITED at £9.8m based on an EBITDA of £1.4m and a 6.94x industry multiple (adjusted for size and gross margin).
biosector 2 limited Estimated Valuation
Pomanda estimates the enterprise value of BIOSECTOR 2 LIMITED at £15.1m based on Net Assets of £6.9m and 2.2x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Biosector 2 Limited Overview
Biosector 2 Limited is a dissolved company that was located in london, WC1A 2SL with a Companies House number of 04460637. It operated in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in June 2002, it's largest shareholder was syneos health communications uk limited with a 100% stake. The last turnover for Biosector 2 Limited was estimated at £3.6m.
Upgrade for unlimited company reports & a free credit check
Biosector 2 Limited Health Check
Pomanda's financial health check has awarded Biosector 2 Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 2 areas for improvement. Company Health Check FAQs
4 Strong
1 Regular
2 Weak
Size
annual sales of £3.6m, make it larger than the average company (£1.5m)
£3.6m - Biosector 2 Limited
£1.5m - Industry AVG
Growth
3 year (CAGR) sales growth of -12%, show it is growing at a slower rate (4.5%)
-12% - Biosector 2 Limited
4.5% - Industry AVG
Production
with a gross margin of 87.4%, this company has a lower cost of product (43.7%)
87.4% - Biosector 2 Limited
43.7% - Industry AVG
Profitability
an operating margin of 38.7% make it more profitable than the average company (6.2%)
38.7% - Biosector 2 Limited
6.2% - Industry AVG
Employees
with 21 employees, this is similar to the industry average (21)
21 - Biosector 2 Limited
21 - Industry AVG
Pay Structure
on an average salary of £94k, the company has a higher pay structure (£46.2k)
£94k - Biosector 2 Limited
£46.2k - Industry AVG
Efficiency
resulting in sales per employee of £173.2k, this is more efficient (£119.8k)
£173.2k - Biosector 2 Limited
£119.8k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Biosector 2 Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Biosector 2 Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Biosector 2 Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Biosector 2 Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Biosector 2 Limited
- - Industry AVG
BIOSECTOR 2 LIMITED financials
Biosector 2 Limited's latest turnover from December 2018 is £3.6 million and the company has net assets of £6.9 million. According to their latest financial statements, Biosector 2 Limited has 21 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 3,637,418 | 4,349,133 | 5,597,324 | 5,332,341 | 5,740,862 | 3,631,021 | 2,197,850 | 1,235,017 | 1,950,354 | 1,943,694 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 459,812 | 836,772 | 850,032 | 1,061,326 | 2,344,354 | 824,236 | 837,980 | 376,286 | 714,689 | 462,638 |
| Gross Profit | 3,177,606 | 3,512,361 | 4,747,292 | 4,271,015 | 3,396,508 | 2,806,785 | 1,359,870 | 858,731 | 1,235,665 | 1,481,056 |
| Admin Expenses | 1,768,521 | 3,472,132 | 3,529,517 | 3,749,168 | 2,986,935 | 2,199,230 | 1,226,052 | 658,197 | 721,630 | 693,766 |
| Operating Profit | 1,409,085 | 40,229 | 1,217,775 | 521,847 | 409,573 | 607,555 | 133,818 | 200,534 | 514,035 | 787,290 |
| Interest Payable | 19 | 374 | 0 | 89 | 2,759 | 258 | 2,548 | 0 | 0 | 0 |
| Interest Receivable | 57,634 | 35,664 | 44,791 | 48,416 | 36,228 | 15,913 | 12,002 | 8,446 | 496 | 141 |
| Pre-Tax Profit | 1,466,700 | 75,519 | 1,262,566 | 570,174 | 443,042 | 623,210 | 143,272 | 208,980 | 514,531 | 787,431 |
| Tax | 0 | -12,623 | 0 | 0 | 0 | 111,852 | -41,966 | -55,380 | -143,383 | -23,408 |
| Profit After Tax | 1,466,700 | 62,896 | 1,262,566 | 570,174 | 443,042 | 735,062 | 101,306 | 153,600 | 371,148 | 764,023 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 1,466,700 | 62,896 | 1,262,566 | 570,174 | 443,042 | 735,062 | 101,306 | 153,600 | 371,148 | 764,023 |
| Employee Costs | 1,972,984 | |||||||||
| Number Of Employees | 21 | 21 | 28 | 26 | ||||||
| EBITDA* | 1,409,085 | 40,229 | 1,217,775 | 521,847 | 409,573 | 607,555 | 133,818 | 200,534 | 514,035 | 787,290 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 10,000,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 10,000,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 26,317 | 90,869 | 205,318 | 157,077 | 41,700 | 61,625 | 18,044 | 35,952 | 94,604 |
| Trade Debtors | 0 | 1,111,006 | 754,399 | 1,390,757 | 711,050 | 550,556 | 290,214 | 220,781 | 538,509 | 515,042 |
| Group Debtors | 6,886,589 | 54,725 | 99,452 | 374,415 | 3,542,284 | 964,605 | 1,918,963 | 2,318,702 | 1,516,878 | 200,301 |
| Misc Debtors | 0 | 144,091 | 194,464 | 407,961 | 196,629 | 309,868 | 78,432 | 92,254 | 36,686 | 171,606 |
| Cash | 0 | 13,240,262 | 8,717,879 | 4,446,405 | 8,249,207 | 3,729,119 | 315,442 | 183,713 | 370,451 | 1,244,156 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 6,886,589 | 14,576,401 | 9,857,063 | 6,824,856 | 12,856,247 | 5,595,848 | 2,664,676 | 2,833,494 | 2,498,476 | 2,225,709 |
| total assets | 6,886,589 | 14,576,401 | 9,857,063 | 16,824,856 | 12,856,247 | 5,595,848 | 2,664,676 | 2,833,494 | 2,498,476 | 2,225,709 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 79,290 | 48,374 | 56,026 | 6,981 | 58,536 | 11,609 | 33,880 | 12,657 | 19,113 |
| Group/Directors Accounts | 0 | 7,563,222 | 3,297,947 | 10,228,699 | 8,379,919 | 1,762,093 | 88,680 | 113,119 | 91,459 | 159,911 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 1,514,000 | 1,153,749 | 2,445,704 | 945,094 | 694,008 | 218,238 | 441,652 | 303,117 | 326,590 |
| total current liabilities | 0 | 9,156,512 | 4,500,070 | 12,730,429 | 9,331,994 | 2,514,637 | 318,527 | 588,651 | 407,233 | 505,614 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 0 | 9,156,512 | 4,500,070 | 12,730,429 | 9,331,994 | 2,514,637 | 318,527 | 588,651 | 407,233 | 505,614 |
| net assets | 6,886,589 | 5,419,889 | 5,356,993 | 4,094,427 | 3,524,253 | 3,081,211 | 2,346,149 | 2,244,843 | 2,091,243 | 1,720,095 |
| total shareholders funds | 6,886,589 | 5,419,889 | 5,356,993 | 4,094,427 | 3,524,253 | 3,081,211 | 2,346,149 | 2,244,843 | 2,091,243 | 1,720,095 |
| Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Operating Profit | 1,409,085 | 40,229 | 1,217,775 | 521,847 | 409,573 | 607,555 | 133,818 | 200,534 | 514,035 | 787,290 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | -12,623 | 0 | 0 | 0 | 111,852 | -41,966 | -55,380 | -143,383 | -23,408 |
| Stock | -26,317 | -64,552 | -114,449 | 48,241 | 115,377 | -19,925 | 43,581 | -17,908 | -58,652 | 94,604 |
| Debtors | 5,576,767 | 261,507 | -11,124,818 | 7,723,170 | 2,624,934 | -462,580 | -344,128 | 539,664 | 1,205,124 | 886,949 |
| Creditors | -79,290 | 30,916 | -7,652 | 49,045 | -51,555 | 46,927 | -22,271 | 21,223 | -6,456 | 19,113 |
| Accruals and Deferred Income | -1,514,000 | 360,251 | -1,291,955 | 1,500,610 | 251,086 | 475,770 | -223,414 | 138,535 | -23,473 | 326,590 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | -5,734,655 | 221,818 | 11,157,435 | -5,699,909 | -2,131,207 | 1,724,609 | 146,714 | -216,844 | -805,749 | 128,032 |
| Investing Activities | ||||||||||
| capital expenditure | ||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||
| Financing Activities | ||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -7,563,222 | 4,265,275 | -6,930,752 | 1,848,780 | 6,617,826 | 1,673,413 | -24,439 | 21,660 | -68,452 | 159,911 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||
| interest | 57,615 | 35,290 | 44,791 | 48,327 | 33,469 | 15,655 | 9,454 | 8,446 | 496 | 141 |
| cash flow from financing | -7,505,607 | 4,300,565 | -6,885,961 | 1,897,107 | 6,651,295 | 1,689,068 | -14,985 | 30,106 | -67,956 | 1,116,124 |
| cash and cash equivalents | ||||||||||
| cash | -13,240,262 | 4,522,383 | 4,271,474 | -3,802,802 | 4,520,088 | 3,413,677 | 131,729 | -186,738 | -873,705 | 1,244,156 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -13,240,262 | 4,522,383 | 4,271,474 | -3,802,802 | 4,520,088 | 3,413,677 | 131,729 | -186,738 | -873,705 | 1,244,156 |
biosector 2 limited Credit Report and Business Information
Biosector 2 Limited Competitor Analysis
Perform a competitor analysis for biosector 2 limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other undefined companies, companies in WC1A area or any other competitors across 12 key performance metrics.
biosector 2 limited Ownership
BIOSECTOR 2 LIMITED group structure
Biosector 2 Limited has no subsidiary companies.
Ultimate parent company
SYNEOS HEALTH INC
#0067791
2 parents
BIOSECTOR 2 LIMITED
04460637
biosector 2 limited directors
Biosector 2 Limited currently has 1 director, Mr Philip Ward serving since Dec 2018.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Philip Ward | England | 57 years | Dec 2018 | - | Director |
P&L
December 2018turnover
3.6m
-16%
operating profit
1.4m
+3403%
gross margin
87.4%
+8.17%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2018net assets
6.9m
+0.27%
total assets
6.9m
-0.53%
cash
0
-1%
net assets
Total assets minus all liabilities
biosector 2 limited company details
company number
04460637
Type
Private limited with Share Capital
industry
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
June 2002
age
23
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2018
previous names
N/A
accountant
-
auditor
BUZZACOTT LLP
address
10 bloomsbury way, london, WC1A 2SL
Bank
THE ROYAL BANK OF SCOTLAND PLC
Legal Advisor
-
biosector 2 limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to biosector 2 limited.
biosector 2 limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BIOSECTOR 2 LIMITED. This can take several minutes, an email will notify you when this has completed.
biosector 2 limited Companies House Filings - See Documents
| date | description | view/download |
|---|
